January 27, 2005 

WORCESTER, Mass.- Steven N. Treistman, PhD, an internationally-recognized researcher on the molecular basis of the effects of alcohol on the brain, has been appointed Director of the Brudnick Neuropsychiatric Research Institute in the Department of Psychiatry of the University of Massachusetts Medical School (UMMS). The Brudnick Institute, which opened in 2000, was founded by UMMS, with support from the Massachusetts Department of Mental Health and the generous contributions of Irving S. and Betty Brudnick, after whom the facility is named.

The Institute's mission is to advance knowledge of the causes, treatment, and prevention of mental disorders, including substance abuse, through its program of neuroscience research. In addition to its laboratories, the Institute includes the Center for Comparative Neuroimaging, where cutting-edge research is performed, using functional imaging of the brain.

Current Institute faculty pursue studies of neurotransmitter receptors and reuptake mechanisms, epigenetic modification of DNA and its relationship to developmental and mental disorders, brain mechanisms underlying addiction, and the genetics of degenerative and mental disorders, among other areas of research. For more information on the Brudnick Institute visit

"Dr. Treistman will add strength in understanding addictive disorders, and will look to expand the Institute's contributions in this critical area," said Paul S. Appelbaum, MD, the Arnold F. Zeleznik Professor and chair of Psychiatry.

Treistman received his PhD in Neurobiology from the University of North Carolina and undertook post-doctoral research fellowships at New York University School of Medicine and the Friedrich Miescher-Institut in Basel, Switzerland. He taught in the Department of Biology at Bryn Mawr College, before moving to the Worcester Foundation for Experimental Biology (now the Worcester Foundation for Biomedical Research, which became part of UMMS in 1997) in Shrewsbury, where he was Senior Scientist. In 1991, Treistman joined UMMS.

Treistman reviews grants for the National Institutes of Health (NIH) and the National Science Foundation, and peer reviews submissions for many of the leading science journals. He recently served as Chair of the NIH National Institute of Alcoholism and Alcohol Abuse Board of Scientific Counselors, and is the recipient of an NIH MERIT award. Treistman, who has been serving as Professor and Vice Chair of the Department of Neurobiology at UMMS, will become Professor of Psychiatry, and will retain his role as Director of the UMMS Program in Neuroscience.

The University of Massachusetts Medical School, one of the fastest growing academic health centers in the country, has built a reputation as a world-class research institution, consistently producing noteworthy advances in clinical and basic research.  The Medical School attracts more than $167 million in research funding annually, 80 percent of which comes from federal funding sources. UMMS is the academic partner of UMass Memorial Health Care, the largest health care provider in Central Massachusetts. For more information visit

Alison Duffy, (508) 856-2000